April 25, 2020

Rapid SARS-CoV-2 whole genome sequencing for informed public health decision making in the Netherlands

SARS-CoV-2 is a novel coronavirus that has rapidly spread across the globe. In the Netherlands, the first case of SARS-CoV-2 has been notified on the 27th of February.

Bas B. Oude Munnink, et al.

April 30, 2020

Origin of imported SARS-CoV-2 strains in The Gambia identified from whole genome sequences

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a positive-sense single stranded RNA virus with high human transmissibility.

Abdoulie Kanteh, et al.

March 30, 2020

Africa Contributes SARS-CoV-2 Sequencing to COVID-19 Tracking

In recent years, laboratories on the continent have ramped up genomic sequencing capabilities, offering in-country analyses rather than outsourcing the job.

Ekaterina Pesheva

April 30, 2019

Researchers are using artificial intelligence to identify known and novel resistance genes.

Amber Dance

November 15, 2018

How AI and Genomics Can Help Fight Antibiotic Resistance 

Antimicrobial Resistance (AMR) is a global health threat.

Cami Rosso

May 2, 2019

10 most common drugs targeted by undergrad’s neural network.

Ekaterina Pesheva

January 31, 2018

Several U.S.-based biotechnology companies are developing ways to harness the power of genetics as well as AI in the fight against antibiotic-resistant bacteria.

Abby Norman

May 30, 2018

Machine learning and other technologies are expected to make the hunt for new pharmaceuticals quicker, cheaper and more effective.

Nic Fleming

May 22, 2019

Immune To Drugs: Antimicrobial Resistance Could Kill 10 Million a Year.

Bacteria, viruses and parasites are growing evermore resistant to the drugs that have been developed to combat them.

Nicole Fisher/Forbes



September 30, 2020

Deep Medical Therapeutics joins the Avoca Quality Consortium with a network of over 120 pharma companies. Together they will help clinical research companies increase quality, ensure compliance, and improve efficiency so that medicines can reach patients faster.